VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2015 | Future perspectives in the treatment of acute lymphoblastic leukemia

Dieter Hoelzer • 12 Jun 2015
EHA 2015
Acute Lymphoblastic Leukemia

At the 20th Congress of the European Hematology Association (EHA), Dieter Hoelzer, MD, PhD, of Goethe University Hospital, Frankfurt, Germany, discusses the possibilities of immunotherapy for the treatment of patients with acute lymphoblastic leukemia.

More from Dieter Hoelzer

1:59
CAR T-cells and BiTEs for hematological malignancies
Dieter Hoelzer
2:51
Two important therapies for ALL
Dieter Hoelzer • 22 Jun 2017
4:44
Exploring the potential of T-cell therapy for acute lymphoblastic leukemia
Dieter Hoelzer • 12 Jun 2015
1:57
MRD negativity in ALL
Dieter Hoelzer

Related Videos

1:32
CAR T-cell therapy: the importance of LTFU
Graham Collins
0:42
Treating pediatric patients with hematological malignancies
Claudia Rössig
1:27
Integration of CAR T-cell therapy: working with industry
Graham Collins
3:08
CAR T-cell therapy: the patient's perspective
Bregje Verhoeven
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals